Raymond James cuts ServiceNow stock price target on guidance concerns By Investing.com

Raymond James cut its price target on ServiceNow to $130 from $160 while keeping an Outperform rating, citing narrower upside after 1Q26 results and guidance disappointment tied to acquisition integration, accounting differences, and delayed Middle East deals. The stock is already down 45% over the past six months and 33% year-to-date, though management said 2026 AI-relative ACV expectations are up 50%. The note argues ServiceNow still has strong fundamentals, but investor expectations on growth and AI incremental value have shifted lower.

Analysis

The market is now pricing ServiceNow less as a premium secular compounder and more as a maturing platform with integration drag, which is the right framing for the next few quarters. The key second-order effect is that every large acquisition now raises the burden of proof on “organic” growth quality: even if reported ACV holds up, investors will increasingly haircut the mix because incremental scale is being bought, not purely won. That can compress the multiple faster than fundamentals deteriorate, especially when the stock already sits in the penalty box.

The AI disclosure cuts both ways. If AI-relative ACV targets are being raised materially, the market should stop treating AI as optional upside and start underwriting it as a core monetization lever that must offset slowing core modules. That creates a near-term paradox: bullish for product relevance, but bearish for margin optics if AI revenue comes with heavier implementation, partner, or compute-related costs. In other words, the real question is no longer “does AI help?” but “does AI preserve incremental FCF conversion?”

Consensus is likely underestimating how much of the downside is already tied to narrative damage rather than numbers. If management can re-anchor expectations at the analyst day / Knowledge conference with cleaner segment disclosure and a credible path to integration synergies, the stock can rebound sharply because positioning is probably light after a 6-month reset. But if guidance still reads as acquisition-mediated and geographically lumpy, the multiple can keep de-rating even on decent absolute growth.

The most important catalyst window is the next 2-6 weeks, not the full-year guide. We would not chase the long side until the market sees whether the company can separate organic demand from acquisition accounting and whether AI ACV is margin-accretive. The setup is asymmetric: poor disclosure can trigger another leg down, while a cleaner framework could unlock a sharp re-rate because expectations have been sufficiently flushed.

Key Decisions for Investors

• Avoid adding to outright NOW longs ahead of the next catalyst window; wait for analyst day / Knowledge conference for proof that growth is organic and AI is accretive. Risk/reward is poor until disclosure clarity improves.
• Sell near-dated NOW put spreads or own a small tactical short into the event if you believe management will remain vague on integration and AI economics. The trade works if the market keeps hair-cutting the multiple on narrative risk rather than earnings misses.
• For longer-term accounts, consider a conditional long NOW only on a post-event washout if the stock retests the low-$90s and management demonstrates stable organic ACV. That offers better upside if the multiple mean-reverts from depressed levels.
• Pair idea: long a clearer AI monetization beneficiary versus NOW (e.g., APP on execution momentum) and short NOW on integration overhang. The relative trade isolates narrative dilution and multiple compression risk inside enterprise software.
• Trim or hedge existing NOW positions into the event; the stock can still work fundamentally, but the next 1-2 quarters are more about trust restoration than earnings power.